Current pediatrics最新文献_第8页

Clinical Phenotypes of Malnutrition in Young Children: Differential Nutritional Correction 幼儿营养不良的临床表型:差异营养矫正

Current pediatrics Pub Date : 2023-01-02 DOI: 10.15690/vsp.v21i6.2495

I. Belyaeva, E. Bombardirova, E. Prihodko, A. Kruglyakov, A. A. Mikheeva, A. R. Larina

引用次数: 0

Functional Near-Infrared Spectroscopy as Promising Method for Studying Cognitive Functions in Children 功能近红外光谱作为研究儿童认知功能的有前途的方法

Current pediatrics Pub Date : 2023-01-02 DOI: 10.15690/vsp.v21i6.2490

L. Yatsyk, G. Karkashadze, V. Altunin, I. A. Povalyaeva, P. A. Prudnikov, L. Namazova-Baranova, E. Vishneva

引用次数: 0

New Strategies for Enhancement of Infant Milk Formulas Composition 提高婴幼儿配方奶粉成分的新策略

Current pediatrics Pub Date : 2022-12-30 DOI: 10.15690/vsp.v21i6.2468

I. Belyaeva, E. Bombardirova, T. Turti

引用次数: 0

The Appearance and Establishment of Breastfeeding Amongst Animals: From Echidna and Platypus to Mammals and Human 哺乳动物的出现和建立:从针鼹和鸭嘴兽到哺乳动物和人类

Current pediatrics Pub Date : 2022-12-29 DOI: 10.15690/vsp.v21i6.2492

S. Ukraintsev, T. Samal

引用次数: 0

Vitamin D Supplementation of 7–8 Years Old Children from Different Geographical Areas (48–52° North Latitude): Cross Sectional Study 不同地理区域(北纬48-52°)7-8岁儿童维生素D补充的横断面研究

Current pediatrics Pub Date : 2022-12-29 DOI: 10.15690/vsp.v21i6.2461

O. Senkevich, Maria A. Chernobrovkina, Yu. G. Kovalsky

{"title":"Vitamin D Supplementation of 7–8 Years Old Children from Different Geographical Areas (48–52° North Latitude): Cross Sectional Study","authors":"O. Senkevich, Maria A. Chernobrovkina, Yu. G. Kovalsky","doi":"10.15690/vsp.v21i6.2461","DOIUrl":"https://doi.org/10.15690/vsp.v21i6.2461","url":null,"abstract":"Background. The prevalence of vitamin D deficiency in children by their geographic latitude of residence requires follow-up study. This is crucial for implementation of preventive measures that can reduce the risk of developing pathological conditions associated with vitamin D deficiency.Objective. The aim of the study is to study the vitamin D supplementation of 7–8 years old children living in different geographical latitudes of one subject of Russian Federation.Methods. The study included relatively healthy children living in three geographical areas (northern — 52°, central — 50°, southern — 48°) of one region (Khabarovsk Krai). Vitamin D supplementation was evaluated by 25(OH)D serum concentration via enzyme-linked immunosorbent assay. Vitamin D insufficiency was diagnosed at 25(OH)D concentration of 21–30 ng/ml, deficiency — 10–20 ng/ml, severe deficiency — < 10 ng/ml; optimal 25(OH)D concentration was considered as 30–100 ng/ml.Results. The increase in prevalence of vitamin D deficiency and insufficiency has been revealed with gradual increase from southern (57%) to central (73%) and northern (83%) geographic areas in 7–8 years old children living in the same region. The prevalence of vitamin D deficiency and insufficiency (25(OH)D ≤ 30 ng/mL) among children living in the northern geographic area was greater by 3.8-fold (95% confidence interval 1.2–12.7) then among peers living in the southern areas.Conclusion. One factor affecting 25(OH)D serum concentration in children of this region is the insolation level determined by the geographical latitude of residence. The 4°N difference is significant in determining vitamin D status in residents of relatively high latitudes. Further studies of factors associated with 25(OH)D concentration in children living in different latitudes are required (insolation level, number of sunny days per year, food and household characteristics in families).","PeriodicalId":10867,"journal":{"name":"Current pediatrics","volume":"45 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85533368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Choice of Product for Mixed or Formula Feeding of Infant: Beneficial Properties of Goat’s Milk Formula 婴儿混合或配方喂养产品的选择:羊奶配方的有益特性

Current pediatrics Pub Date : 2022-12-29 DOI: 10.15690/vsp.v21i6.2469

I. Belyaeva, E. Bombardirova, T. Turti

引用次数: 0

World Trends in Infant Formulas Composition Enhancement 提高婴儿配方奶粉成分的世界趋势

Current pediatrics Pub Date : 2022-12-29 DOI: 10.15690/vsp.v21i6.2479

I. Belyaeva, L. Namazova-Baranova, E. Bombardirova, T. Turti

引用次数: 0

Fibrodysplasia Ossificans Progressiva: Literature Review and Case Report 进行性骨化性纤维发育不良:文献回顾及病例报告

Current pediatrics Pub Date : 2022-12-29 DOI: 10.15690/vsp.v21i6s.2482

N. N. Korableva, E. V. Berestnev, Sergey M. Kiselyov, N. Chipsanova

{"title":"Fibrodysplasia Ossificans Progressiva: Literature Review and Case Report","authors":"N. N. Korableva, E. V. Berestnev, Sergey M. Kiselyov, N. Chipsanova","doi":"10.15690/vsp.v21i6s.2482","DOIUrl":"https://doi.org/10.15690/vsp.v21i6s.2482","url":null,"abstract":"Background. Fibrodysplasia ossificans progressiva (FOP) is a genetic disease of the heterotopic ossification group associated with the mutation in ACVR1/ALK2 gene. FOP is characterized by progressive heterotopic endochondral ossification of connective tissue that occurs in postnatal period. It leads to formation of qualitatively normal bone in extraskeletal areas. Congenital hallux deformity is typical for this disease. The clinical picture is characterized by aggravations that are usually caused by trauma or viral infections. Formation of Heterotopic ossificate formation can be observed during aggravations. There is no etiological treatment for FOP. Systemic glucocorticosteroids, non-steroidal anti-inflammatory drug (NSAIDs), mast cell stabilisers, antileukotriene drugs and bisphosphonates can be used in these patients. Clinical case description. The child was born with congenital hallux deformity typical for FOP. The disease onset was noted at the age of 2 years 8 months with a tumor-like painful mass on the neck. Oncological (lymphoproliferative) disease was suspected but biopsy from the lesion did not confirm its malignant nature. The child was consulted by pediatric rheumatologist who has diagnosed FOP. Etanercept and zoledronic acid were administrated, though etanercept was later discontinued. For now, the child receives zoledronic acid infusions 2 times per year and daily NSAIDs. Conclusion. The difficulties in FOP diagnosing are associated to its sporadic nature and clinical picture similarity to other diseases. Suspected malignancy leads to biopsy that is highly undesirable in FOP patients due to high risk of iatrogenic complications.","PeriodicalId":10867,"journal":{"name":"Current pediatrics","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82859594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Results of 14-year-long Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II: Clinical Case 1例ⅱ型粘多糖病患者14年酶替代治疗的临床结果

Current pediatrics Pub Date : 2022-12-29 DOI: 10.15690/vsp.v21i6s.2478

N. Zhurkova, N. Vashakmadze, Ludmila K. Mikhaylova, Marina A. Babaykina, N. Fedorova, E. Voskoboeva, E. Zakharova, L. Namazova-Baranova

{"title":"Results of 14-year-long Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II: Clinical Case","authors":"N. Zhurkova, N. Vashakmadze, Ludmila K. Mikhaylova, Marina A. Babaykina, N. Fedorova, E. Voskoboeva, E. Zakharova, L. Namazova-Baranova","doi":"10.15690/vsp.v21i6s.2478","DOIUrl":"https://doi.org/10.15690/vsp.v21i6s.2478","url":null,"abstract":"Background. Mucopolysaccharidosis type II (MPS II) is a rare hereditary disease from the group of lysosomal storage diseases, with progressive course. There is effective enzyme replacement therapy (ERT) for this disease, it prevents the development of severe complications and improves patients’ quality of life. Long-term follow-up of health changes in individuals on ERT is required for evaluating the treatment impact on disease progression and eventually on the quality of life of the patient and his family. Clinical case description. Results of 14-year-long follow-up of the patient with MPS II who was the first patient on ERT with idursulfase in Russia are presented. Improvement of growth, decrease in ENT-organs infections frequency, liver and spleen sizes decrease, general stabilization, no progression in cardiovascular and respiratory events, normal levels of glycosaminoglycans in urine are shown. Conclusion. Long-term therapy with idursulfase in severe MPS II stabilizes the patient’s somatic condition, prevents the development of severe complications in cardiovascular and respiratory systems, improves the quality of life of the patient and his family. Urinary glycosaminoglycans level decrease is the important indicator of the therapy efficacy along with overall patient's somatic state.","PeriodicalId":10867,"journal":{"name":"Current pediatrics","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88866779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Scientific and Practical Innovations in Restoring Skin Barrier Properties in Children with Atopic Dermatitis 特应性皮炎患儿皮肤屏障特性恢复的科学与实践创新

Current pediatrics Pub Date : 2022-11-02 DOI: 10.15690/vsp.v21i5.2457

N. Murashkin, R. N. Nezhvedilova, D. V. Fedorov, R. Epishev, R. A. Ivanov, A. I. Materikin, L. A. Opryatin, A. A. Savelova, L. L. Rusakova

引用次数: 0